Randomized phase II study of the efficacy and safety of gemcitabine plus TH-302 versus gemcitabine alone in previously untreated patients with advanced pancreatic cancer
Borad, M. J., Sigal, D., Uronis, H., Stephenson, J., Bahary, N., Rarick, M. U., DeMarco, L. C., Finnegan, T. J., Chiorean, E. G., Ryan, D. P., Cohn, A. L., Ulrich, B. K., Harish, V. C., Anderes, E. N., Ma, W. W., Yu, P. P., Sinicrope, F., Eng, C., Sunkara, U. K., Reddy, S. G.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article